Comparison of Everolimus- and Biolimus-Eluting Stents With Everolimus-Eluting Bioresorbable Vascular Scaffold Stents
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 240 participants.
Also called NCT01711931
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 240 participants
- Sponsor
- University of Freiburg
- Registry
-
NCT01711931
-
- Other papers using this trial's data
- Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds
- Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds--an optical coherence tomography substudy of the EVERBIO II trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT01711931. Randomized; single masking; primary purpose treatment. Start 2012-10 (registry gives no type); primary completion 2013-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Everolimus- and Biolimus-Eluting Stents With Everolimus-Eluting Bioresorbable Vascular Scaffold Stents
- Acronym
- EVERBIOII
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Implantation of everolimus-eluting bioresorbable vascular scaffold stent
- Intervention (Device)
- Implantation of everolimus-eluting stents
- Intervention (Device)
- Implantation of biolimus-eluting stents
- Lead sponsor
- University of Freiburg
Record details
- Record id
cardio:ct-nct01711931- Content hash
62ae0c95ef590b2399fe9b19a2294b2b66cc322909959529abaa5b243fe5c18c